Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company developing and delivering innovative therapies in critical care and infectious disease.  Our approved treatments are indicated for use in life-threatening circumstances for seriously ill patients, and our investigational therapies are in development for patients fighting drug-resistant pathogens.

Growing antimicrobial resistance to existing therapies represents an urgent threat to global public health, and is directly related to significant mortality rates and longer, more expensive hospital stays. We are proud to work with physicians, nurses, hospital pharmacists and administrators, and all who devote their time to caring for patients. 

Biotechnology

Health Care

Therapeutics

Innoviva Specialty Therapeutics, Inc.

Innoviva Specialty Therapeutics, Inc.'s headquarters in Waltham, MA, United States

Description

People (18)

David Altarac

April Chen

Ying Wang

Nikki Carter

Maria Angela Tanudra

Dr Olufemi Rabiu

Alexander Jacobine

Courtney S. Henry

Eric Rosenberger

Sarah McLeod

Anna Chow

Kristen Aldweib

Irina Elkin

Gregg Ciarelli

Shruta Rege

Kevin Conley

Drew Lewis

Peter Douglass

Jobs